Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the μ-opioid receptor in HEK 293 cells

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 414-422

  Schmidt, Harald ^a   Schulz, Stefan ^a   Klutzny, Marcus ^a   Koch, Thomas ^a   Händel, Manuela ^a   Höllt, Volker ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Opioid receptor; Desensitization; Internalization; Mitogen activated protein kinase; Opioids; Receptor phosphorylation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MU OPIATE RECEPTOR; NALOXONE;

ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; MITOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

BUTADIENES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PHOSPHORYLATION; RECEPTORS, OPIOID, MU;

TRIXIS;

EID: 0033962013     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740414.x     Document Type: Article

References (38)

1. 2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J. Biol. Chem. 274, 1185-1188.
2. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., and Saltiel A. R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
3. Arden J. R., Segredo V., Wang Z., Lameh J., and Sadée W. (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65, 1636-1645.
4. βγ subunits. J. Neurochem. 70, 635-645.
5. Burt A. R., Carr I. C., Mullaney I., Anderson N. G., and Milligan G. (1996) Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse δ opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation. Biochem. J. 320, 227-235.
6. Chuang L. F., Killam K. F., and Chuang R. Y. (1997) Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate. J. Biol. Chem. 272, 26815-26817.
7. Cvejic S. and Devi L. A. (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272, 26959-26964.
8. Daaka Y., Luttrell L. M., Ahn S., Della Rocca G. J., Ferguson S. S. G., Caron M. G., and Lefkowitz R. J. (1998) Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J. Biol. Chem. 273, 685-688.
9. 2-adrenergic receptor subtypes. J. Biol. Chem. 274, 11253-11259.
10. 1a receptor mediated erk activation requires calcium/calmodulin-dependent receptor endocytosis. J. Biol. Chem. 274, 4749-4753.
11. DeSilva D. R., Jones E. A., Favata M. F., Jaffee B. D., Magolda R. L., Trzaskos J. M., and Scherle P. A. (1998) Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol. 160, 4175-4181.
12. Dudley D. T., Pang L., Decker S. J., Bridges A. J., and Saltiel A. R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92, 7686-7689.
13. Duncia J. V., Santella J. B. 3rd, Higley C. A., Pitts W. J., Wityak J., Frietze W. E., Rankin F. W., Sun J. H., Earl R. A., Tabaka A. C., Teleha C. A., Blom K. F., Favata M. F., Manos E. J., Daulerio A. J., Stradley D. A., Horiuchi K., Copeland R. A., Scherle P. A., Trzaskos J. M., Magolda R. L., Trainor G. L., Wexler R. R., Hobbs F. W., and Olson R. E. (1998) MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg. Med. Chem. Lett. 8, 2839-2844.
14. Favata M. F., Horiuchi K. Y., Manos E. J., Daulerio A. J., Stradley D. A., Feeser W. S., Van Dyk D. E., Pitts W. J., Earl R. A., Hobbs F., Copeland R. A., Magolda R. L., Scherle P. A., and Trzaskos J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
15. Fukuda K., Kato S., Morikawa H., Shoda T., and Mori K. (1996) Functional coupling of the δ, μ, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 67, 1309-1316.
16. 1-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization. J. Neurochem. 71, 1024-1033.
17. Ignatova E. G., Belcheva M. M., Bohn L. M., Neuman M. C., and Coscia C. J. (1999) Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. J. Neurosci. 19, 56-63.
18. Iwata R., Ito H., Hayashi T., Sekine Y., Koyama N., and Yamaki M. (1995) Stable and general-purpose chemiluminescent detection system for horseradish peroxidase employing a thiazole compound enhancer and some additives. Anal Biochem. 231, 170-174.
19. Jacobs D., Glossip D., Xing H., Muslin A. J., and Kornfeld K. (1999) Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13, 163-175.
20. Jordan B. A. and Devi L. A. (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700.
21. Keith D. E., Murray S. R., Zaki A. P., Chu P. C., Lissin D. V., Kang L., Evans C. J., and von Zastrow M. (1996) Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024.
22. Koch T., Kroslak T., Mayer P., Raulf E., and Höllt V. (1997) Site mutation in the rat μ-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J. Neurochem. 69, 1767-1770.
23. Koch T., Schulz S., Schröder H., Wolf R., Raulf E., and Höllt V. (1998) Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273, 13652-13657.
24. Lefkowitz R. J. (1998) G protein-coupled receptors. III. New roles for receptor kinases and β arrestins in receptor signaling and desensitization. J. Biol. Chem. 273, 18677-18680.
25. Li J. G., Luo L. Y., Krupnick J. G., Benovic J. L., and Liu-Chen L. Y. (1999) U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J. Biol. Chem. 274, 12087-12094.
26. Li L. Y. and Chang K. J. (1996) The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express μ-opioid receptors. Mol. Pharmacol. 50, 599-602.
27. 2 adrenergic receptor-src protein kinase complexes, Science 283, 655-661.
28. Pak Y., O'Dowd B. F., and George S. R. (1997) Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J. Biol. Chem. 272, 24961-24965.
29. Polakiewicz R. D., Schieferl S. M., Dorner L. F., Kansra V., and Comb M. J. (1998) A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization. J. Biol. Chem. 273, 12402-12406.
30. Scherle P. A., Jones E. A., Favata M. F., Daulerio A. J., Covington M. B., Nurnberg S. A., Magolda R. L., and Trzaskos J. M. (1998) Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J. Immunol. 161, 5681-5686.
31. Schulz S. and Höllt V. (1998) Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur. J. Neurosci. 10, 1196-1201.
32. Schulz S., Schreff M., Koch T., Zimprich A., Gramsch C., and Höllt V. (1998) Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience 82, 613-622.
33. Seger R. and Krebs E. G. (1995) The MAPK signaling cascade. FASEB J. 9, 726-735.
34. Sternini C., Spann M., Anton B., Keith D. E. Jr., Bunnett N. W., von Zastrow M., Evans C., and Brecha N. C. (1996) Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc. Natl. Acad Sci. USA 93, 9241-9246.
35. Whistler J. L. and von Zastrow M. (1998) Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc. Natl. Acad. Sci. USA 95, 9914-9919.
36. Wolf R., Koch T., Schulz S., Klutzny M., Schröder H., Raulf E., Bühling F., and Höllt V. (1999) Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat μ opioid receptor. Mol. Pharmacol. 55, 263-268.
37. 1 receptors. J. Neurosci. 17, 1660-1669.
38. Zhang J., Ferguson S. S., Barak L. S., Bodduluri S. R., Laporte S. A., Law P.-Y., and Caron M. G. (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95, 7157-7162.